Celgene Corp. buy geldnutzer
Start price
26.01.17
/
50%
€103.28
Target price
13.11.17
€141.43
Performance (%)
-10.62%
End price
13.11.17
€92.31
Summary
This prediction ended on 13.11.17 with a price of €92.31. The price of Celgene Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.62%. geldnutzer has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by geldnutzer for this prediction
In the thread Celgene Corp. diskutieren
Die Zukunftsaussichten sind positiv.
Celgene ist eine der besten Biotechwerte. Auf dem Niveau sollte der Weg weiter nach oben gehen.
(Laufzeit überschritten)